Cefixime Patent Expiration
Cefixime is Used for treating bacterial infections. It was first introduced by Lederle Laboratories Div American Cyanamid Co
Cefixime Patents
Given below is the list of patents protecting Cefixime, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Suprax | US9233112 | Pharmaceutical compositions of cefixime | Dec 14, 2028 | Lupin Ltd |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Cefixime Generics
Several generic applications have been filed for Cefixime. The first generic version for Cefixime was by Lupin Pharmaceuticals Inc and was approved on Feb 12, 2004. And the latest generic version is by Alkem Laboratories Ltd and was approved on Feb 19, 2021.
Given below is the list of companies who have filed for Cefixime generic.
1. BELCHER
Belcher Pharmaceuticals Llc has filed for 3 different strengths of generic version for Cefixime. Given below are the details of the strengths of this generic introduced by Belcher.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/5ML | for suspension | Prescription | ORAL | AB | Feb 6, 2017 |
| 200MG/5ML | for suspension | Prescription | ORAL | AB | Feb 6, 2017 |
| 500MG/5ML | for suspension | Prescription | ORAL | AB | Feb 6, 2017 |
2. LUPIN LTD
Lupin Ltd has filed for 3 different strengths of generic version for Cefixime. All of these versions come by the name SUPRAX. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet, chewable | Prescription | ORAL | N/A | Oct 25, 2010 |
| 150MG | tablet, chewable | Prescription | ORAL | N/A | Oct 25, 2010 |
| 200MG
(reference standard) | tablet, chewable | Prescription | ORAL | N/A | Oct 25, 2010 |
3. SANDOZ
Sandoz Inc has filed for 2 different strengths of generic version for Cefixime. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG/5ML | for suspension | Discontinued | ORAL | N/A | Nov 17, 2017 |
| 100MG/5ML | for suspension | Discontinued | ORAL | N/A | Nov 17, 2017 |
4. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Cefixime. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/5ML | for suspension | Prescription | ORAL | AB | Apr 14, 2015 |
| 200MG/5ML | for suspension | Prescription | ORAL | AB | Apr 14, 2015 |
5. LUPIN PHARMS
Lupin Pharmaceuticals Inc has filed for 3 different strengths of generic version for Cefixime. All of these versions come by the name SUPRAX. Given below are the details of the strengths of this generic introduced by Lupin Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 400MG | tablet | Discontinued | ORAL | N/A | Feb 12, 2004 |
| 100MG/5ML | for suspension | Discontinued | ORAL | N/A | Feb 23, 2004 |
| 200MG/5ML
(reference standard) | for suspension | Prescription | ORAL | AB | Apr 10, 2007 |
6. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 3 different strengths of generic version for Cefixime. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 400MG | capsule | Prescription | ORAL | AB | Oct 9, 2018 |
| 100MG/5ML | for suspension | Prescription | ORAL | AB | Feb 19, 2021 |
| 200MG/5ML | for suspension | Prescription | ORAL | AB | Feb 19, 2021 |